Literature DB >> 12242149

Focus on sarcomas.

Crystal L Mackall1, Paul S Meltzer, Lee J Helman.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12242149     DOI： 10.1016/s1535-6108(02)00132-0

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  35 in total

1.  Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo.

Authors:  David E Joyner; Mark L Wade; Aniko Szabo; Jeffrey Bastar; Cheryl M Coffin; Karen H Albritton; Philip S Bernard; R Lor Randall
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-22       Impact factor: 4.553

2.  CDK4/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest.

Authors:  Ashleigh M Francis; Angela Alexander; Yanna Liu; Smruthi Vijayaraghavan; Kwang Hui Low; Dong Yang; Tuyen Bui; Neeta Somaiah; Vinod Ravi; Khandan Keyomarsi; Kelly K Hunt
Journal:  Mol Cancer Ther       Date:  2017-06-15       Impact factor: 6.261

3.  Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers.

Authors:  Giulia Grisendi; Rita Bussolari; Elena Veronesi; Serena Piccinno; Jorge S Burns; Giorgio De Santis; Pietro Loschi; Marco Pignatti; Fabrizio Di Benedetto; Roberto Ballarin; Carmela Di Gregorio; Valentina Guarneri; Lino Piccinini; Edwin M Horwitz; Paolo Paolucci; Pierfranco Conte; Massimo Dominici
Journal:  Am J Cancer Res       Date:  2011-05-28       Impact factor: 6.166

4.  Universal marker and detection tool for human sarcoma circulating tumor cells.

Authors:  Arun Satelli; Abhisek Mitra; Jeffry J Cutrera; Marcos Devarie; Xueqing Xia; Davis R Ingram; Denada Dibra; Neeta Somaiah; Keila E Torres; Vinod Ravi; Joseph A Ludwig; Eugenie S Kleinerman; Shulin Li
Journal:  Cancer Res       Date:  2014-01-21       Impact factor: 12.701

5.  Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency.

Authors:  Jinhyang Choi; Stephen J Curtis; David M Roy; Andrea Flesken-Nikitin; Alexander Yu Nikitin
Journal:  Am J Pathol       Date:  2010-09-23       Impact factor: 4.307

6.  EGFR expression in circulating tumor cells from high-grade metastatic soft tissue sarcomas.

Authors:  Alexcia Camila Braun; Celso Abdon Lopes de Mello; Marcelo Corassa; Emne Ali Abdallah; Ana Cláudia Urvanegia; Vanessa Silva Alves; Bianca C T C P Flores; Mônica Díaz; Ulisses Ribaldo Nicolau; Virgilio Souza E Silva; Vinicius Calsavara; Patrizia Paterlini-Brechót; Ludmilla Thomé Domingos Chinen
Journal:  Cancer Biol Ther       Date:  2018-03-21       Impact factor: 4.742

7.  Characterization of three newly established rat sarcoma cell clones.

Authors:  Monika Holubova; Martin Leba; Markéta Sedmikova; Luca Vannucci; Vratislav Horak
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-11-13       Impact factor: 2.416

8.  EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model.

Authors:  Iranzu González; Silvestre Vicent; Enrique de Alava; Fernando Lecanda
Journal:  J Mol Med (Berl)       Date:  2007-04-24       Impact factor: 4.599

Review 9.  Mouse models for cancer stem cell research.

Authors:  Le Cheng; Anirudh V Ramesh; Andrea Flesken-Nikitin; Jinhyang Choi; Alexander Yu Nikitin
Journal:  Toxicol Pathol       Date:  2009-11-17       Impact factor: 1.902

Review 10.  Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.

Authors:  M Mimeault; S K Batra
Journal:  Panminerva Med       Date:  2008-03       Impact factor: 5.197
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.